171 related articles for article (PubMed ID: 33965490)
21. Fabrication of carboxymethyl chitosan/poly(ε-caprolactone)/doxorubicin/nickel ferrite core-shell fibers for controlled release of doxorubicin against breast cancer.
Abasalta M; Asefnejad A; Khorasani MT; Saadatabadi AR
Carbohydr Polym; 2021 Apr; 257():117631. PubMed ID: 33541657
[TBL] [Abstract][Full Text] [Related]
22. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
23. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
24. Synthesis of magnetic chitosan/hyaluronic acid/κ-carrageenan nanocarriers for drug delivery.
Anbardan MA; Alipour S; Mahdavinia GR; Rezaei PF
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126805. PubMed ID: 37689291
[TBL] [Abstract][Full Text] [Related]
25. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
26. Influence of pH-responsive compounds synthesized from chitosan and hyaluronic acid on dual-responsive (pH/temperature) hydrogel drug delivery systems of Cortex Moutan.
Chatterjee S; Hui PC; Siu WS; Kan CW; Leung PC; Wanxue C; Chiou JC
Int J Biol Macromol; 2021 Jan; 168():163-174. PubMed ID: 33309656
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer.
Wang Y; Qian J; Yang M; Xu W; Wang J; Hou G; Ji L; Suo A
Carbohydr Polym; 2019 Dec; 225():115206. PubMed ID: 31521263
[TBL] [Abstract][Full Text] [Related]
30. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
Campos J; Varas-Godoy M; Haidar ZS
Nanomedicine (Lond); 2017 Mar; 12(5):473-490. PubMed ID: 28181464
[TBL] [Abstract][Full Text] [Related]
33. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
34. Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery.
Cheng Y; Cai H; Yin B; Yao P
Int J Pharm; 2013 Sep; 454(1):425-34. PubMed ID: 23830946
[TBL] [Abstract][Full Text] [Related]
35. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
Esfandiarpour-Boroujeni S; Bagheri-Khoulenjani S; Mirzadeh H; Amanpour S
Carbohydr Polym; 2017 Jul; 168():14-21. PubMed ID: 28457434
[TBL] [Abstract][Full Text] [Related]
36. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C
Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958
[TBL] [Abstract][Full Text] [Related]
37. Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
Chen H; Fan X; Zhao Y; Zhi D; Cui S; Zhang E; Lan H; Du J; Zhang Z; Zhang S; Zhen Y
ACS Appl Mater Interfaces; 2020 May; 12(19):22074-22087. PubMed ID: 32083833
[TBL] [Abstract][Full Text] [Related]
38. Radio-frequency triggered heating and drug release using doxorubicin-loaded LSMO nanoparticles for bimodal treatment of breast cancer.
Kulkarni VM; Bodas D; Dhoble D; Ghormade V; Paknikar K
Colloids Surf B Biointerfaces; 2016 Sep; 145():878-890. PubMed ID: 27337564
[TBL] [Abstract][Full Text] [Related]
39. Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin.
Termsarasab U; Yoon IS; Park JH; Moon HT; Cho HJ; Kim DD
Int J Pharm; 2014 Apr; 464(1-2):127-34. PubMed ID: 24451239
[TBL] [Abstract][Full Text] [Related]
40. Improvement of the Antioxidant and Antitumor Activities of Benzimidazole-Chitosan Quaternary Ammonium Salt on Drug Delivery Nanogels.
Ma B; Li Q; Zhang J; Mi Y; Tan W; Guo Z
Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38248665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
